首页|期刊导航|世界中西医结合杂志|复方四黄液通过调控TLR2/4-IL-6/TNF信号轴及铁死亡通路抑制骨折术后感染的机制研究

复方四黄液通过调控TLR2/4-IL-6/TNF信号轴及铁死亡通路抑制骨折术后感染的机制研究OA

Mechanisms of Compound Sihuang Liquid in Inhibiting Postoperative Fracture Infection by Modulating the TLR2/4‒IL-6/TNF Axis and Ferroptosis Pathway

中文摘要英文摘要

目的 探讨复方四黄液通过调控TLR2/4-IL-6/TNF信号轴及铁死亡通路抑制骨折术后感染的分子机制.方法 采用网络药理学筛选复方四黄液的活性成分及细菌感染相关靶点,并进行基因本体(gene ontology,GO)功能注释及京都基因与基因组百科全书(kyoto encyclopedia of genes and genomes,KEGG)通路富集分析,结合分子对接验证核心靶点与活性成分的结合能力.将40只SPF级大白兔按随机数字表法分为对照组、复方四黄液组、万古霉素组、复方四黄液+Fer-1组、复方四黄液+Erastin组,每组8只.各组大白兔建立兔骨折术后感染模型,对照组予生理盐水灌胃,复方四黄液组予复方四黄液灌胃,万古霉素组予腹腔注射盐酸万古霉素溶液,复方四黄液+Fer-1组予复方四黄液灌胃联合腹腔注射铁死亡抑制剂Ferrostatin-1,复方四黄液+Erastin组予复方四黄液灌胃联合腹腔注射铁死亡激动剂Erastin,均1次/d,连续干预15 d.采用Western blot法检测滑膜组织长链脂酰辅酶A合成酶4(acyl-CoA synthetase long-chain family member 4,ACSL4)、环氧合酶-2(cyclooxygenase-2,COX-2)、谷胱甘肽过氧化物酶4(glutathione peroxidase 4,GPX4)、白细胞介素-6(interleukin-6,IL-6)、Toll样受体2(toll-like receptor 2,TLR2)、Toll样受体4(toll-like receptor 4,TLR4)、肿瘤坏死因子-α(tumor necrosis factor-alpha,TNF-α)、甘油醛-3-磷酸脱氢酶(glyceraldehyde-3-phosphate dehydrogenase,GAPDH)表达水平;采用ELISA法检测血清丙二醛(malondialdehyde,MDA)、IL-6、TNF-α表达水平.结果 网络药理学结果显示,共筛选出复方四黄液活性成分117个,与细菌感染靶点交集基因81个,核心靶点为IL-6及TNF.分子对接显示,核心活性成分与关键靶点均具有良好的结合能力.GO与KEGG富集分析提示,复方四黄液主要参与对异种刺激、活性氧及氧化应激的应答,并调控IL-17、TNF及Toll样受体等信号通路.动物实验结果显示,与对照组比较,复方四黄液组滑膜组织ACSL4、COX-2、IL-6、TLR2、TLR4、TNF-α表达明显降低,GPX4表达明显升高(P<0.001);血清MDA、IL-6、TNF-α表达明显降低(P<0.001).与万古霉素组比较,复方四黄液组滑膜组织ACSL4、TLR2、TLR4明显降低,GPX4明显升高(P<0.001);两组血清MDA、IL-6、TNF-α比较,差异无统计学意义(P>0.05).与复方四黄液组比较,复方四黄液+Fer-1组滑膜组织ACSL4、COX-2、IL-6、TLR2、TLR4、TNF-α表达明显降低,GPX4表达明显升高(P<0.001),血清MDA、IL-6、TNF-α表达明显降低(P<0.05);而复方四黄液+Erastin组滑膜组织ACSL4、COX-2、IL-6、TLR2、TLR4、TNF-α表达明显升高,GPX4表达明显降低(P<0.001),血清MDA、IL-6、TNF-α表达明显升高(P<0.05).结论 复方四黄液可通过抑制TLR2/4-IL-6/TNF信号轴及铁死亡进程,发挥控制骨折术后感染的作用.

Objective To investigate the mechanism of Compound Sihuang Liquid in inhibiting postoperative fracture infection via modulating the TLR2/4-IL-6/TNF signaling axis and ferroptosis pathway.Methods Network pharmacology was used to identify active components of Compound Sihuang Liquid and their potential targets related to bacterial infection.Gene Ontology(GO)functional annotation and Kyoto Encyclopedia of Genes and Genomes(KEGG)pathway enrichment analysis were conducted.Molecular docking was integrated to verify binding affinities of core targets and active components.In animal experiments,40 SPF-grade white rabbits were divided into a control group,a Compound Sihuang Liquid group,a vancomycin group,a Compound Sihuang Liquid+Fer-1 group,and a Compound Sihuang Liquid+Erastin group using the random number table method,with 8 animals in each group.After modelling postoperative fracture infection,the control group was administered normal saline via gavage;the Compound Sihuang Liquid group was administered the corresponding liquid via gavage;the vancomycin group was administered vancomycin via intraperitoneal injection.The Compound Sihuang Liquid+Fer-1 group was administered the corresponding liquid via gavage and the ferroptosis inhibitor Ferrostatin-1 via intraperitoneal injection,while the Compound Sihuang Liquid+Erastin group was administered the corresponding liquid via gavage and the ferroptosis activator Erastin via intraperitoneal injection.Intervention was given once daily for 15 consecutive days.Then,Western blot was employed to measure Acyl-CoA synthetase long-chain family member 4(ACSL4),cyclooxygenase-2(COX-2),glutathione peroxidase 4(GPX4),interleukin-6(IL-6),Toll-like receptor 2(TLR2),Toll-like receptor 4(TLR4),tumor necrosis factor-alpha(TNF-α),and glyceraldehyde-3-phosphate dehydrogenase(GAPDH)expression levels.Enzyme-linked immunosorbent assay(ELISA)was performed to examine serum malondialdehyde(MDA),IL-6,and TNF-α expression levels.Results According to network pharmacology results,117 active components were screened in Compound Sihuang Liquid,and 81 intersected with targets related to bacterial infection,with IL-6 and TNF being the core targets.Molecular docking revealed favorable binding affinities between the key active components and core targets.GO and KEGG enrichment analyses indicated that Compound Sihuang Liquid was primarily involved in responses to xeno-stimuli,reactive oxygen species,and oxidative stress,while modulating IL-17,TNF,and Toll-like receptor signaling pathways.Animal experiment results revealed that,compared with the control group,the Compound Sihuang Liquid group exhibited significantly decreased ACSL4,COX-2,IL-6,TLR2,TLR4,and TNF-α expression,and significantly increased GPX4 expression in synovial tissues(P<0.001),along with significantly decreased serum MDA,IL-6,and TNF-α expression(P<0.001).Compared with the vancomycin group,the Compound Sihuang Liquid group showed significantly decreased ACSL4,TLR2,and TLR4 expression and significantly increased GPX4 expression in synovial tissues(P<0.001),while no significant intergroup difference was observed in serum MDA,IL-6,or TNF-α expression(P>0.05).Compared with the Compound Sihuang Liquid group,the Compound Sihuang Liquid+Fer-1 group demonstrated significantly decreased ACSL4,COX-2,IL-6,TLR2,TLR4,and TNF-α expression and significantly increased GPX4 expression in synovial tissues(P<0.001),along with significantly decreased serum MDA,IL-6,and TNF-α expression(P<0.05).Similarly,the Compound Sihuang Liquid+Erastin group displayed significantly increased ACSL4,COX-2,IL-6,TLR2,TLR4,and TNF-α expression and significantly decreased GPX4 expression in synovial tissues(P<0.001),along with significantly increased serum MDA,IL-6,and TNF-α expression(P<0.05).Conclusion Compound Sihuang Liquid alleviates postoperative fracture infection by regulating the TLR2/4‒IL-6/TNF signaling axis and ferroptosis pathway,providing a novel strategy for clinical treatment.

龙丽丽;曾展鹏;赖昌荣;万奕辉;植月森;郑伟杰

广州中医药大学,广东 广州 510006||广州市番禺区中医院,广东 广州 511400广州市番禺区中医院,广东 广州 511400广州中医药大学,广东 广州 510006||广州市番禺区中医院,广东 广州 511400广州中医药大学,广东 广州 510006||广州市番禺区中医院,广东 广州 511400广州市番禺区中医院,广东 广州 511400广州市番禺区中医院,广东 广州 511400

医药卫生

复方四黄液铁死亡炎症信号轴细菌感染动物实验

Compound Sihuang Liquidferroptosisinflammatory axisbacterial infectionanimal experiment

《世界中西医结合杂志》 2026 (9)

1752-1759,8

广东省中医药局科研项目(20222162)广州市番禺区科技计划重点医疗卫生项目(2023-Z04-102)

10.13935/j.cnki.sjzx.260910

评论